Director, GCP Quality Assurance
Marea Therapeutics
This listing was originally posted on Marea Therapeutics's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Drug products linked to this role
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moABOUT THE COMPANY
Marea Therapeutics is a clinical-stage biotechnology company based in South San Francisco with a growing pipeline of first-in-class therapies to address genetically validated cardioendocrine disease targets. Our therapies have the potential to serve as transformative treatment options for significant patient populations living with cardioendocrine diseases.
The company’s lead program, MAR001, is being developed for the treatment of severe hypertriglyceridemia (sHTG), a condition characterized by very high triglyceride levels and elevated risk of acute pancreatitis. Preclinical models with MAR001 demonstrated reduction in triglycerides, remnant cholesterol and ectopic fat, and improved insulin sensitivity. MAR001 has demonstrated strong and a differentiated profile in patients and is approaching Phase 3 development. Our second clinical asset, MAR002, is a monoclonal antibody targeting excess growth hormone produced by the pituitary gland in the rare hormonal disorder, acromegaly. MAR002 has potential to become best-in-disease and is quickly progressing into Phase 2/3 clinical development. We also have a third asset that is swiftly advancing through research discovery, with DC nomination expected this year.
At Marea, we believe in the power of collaboration and the importance of leading by example. We are a tight-knit team that values the contributions of every member, from interns to senior leaders. Our environment is dynamic, with each day presenting new challenges and opportunities for growth. Every role is “Hands-On”, and the successful candidate will be able to work alongside team members, regardless of level, to understand challenges and drive results.
ABOUT THE ROLE
We are seeking a motivated Director, Good Clinical Practice (GCP) Quality Assurance to build and lead the GCP quality program supporting Marea’s clinical portfolio. The incumbent will be responsible for Marea’s GCP quality management system, the risk-based clinical audit program, and GCP inspection readiness as our programs advance to Phase 3 clinical development.
This is a hands-on, build-oriented role. The position requires a strong ability to both think strategically and execute directly, planning and conducting audits, authoring procedures, and partnering day to day with clinical study teams, as well as working well independently and in collaboration with internal and external cross-functional teams. The position reports to the Executive Director, Regulatory Affairs and will be involved in the future development and growth of the GCP Quality function. The role carries independent quality judgment and direct escalation authority for material GCP compliance matters.
KEY RESPONSIBILITIES
In compliance with applicable pay transparency laws, the expected base salary range for this position is $205,000 to $235,000 annually. This range represents the Company's good faith estimate of the salary range for this role at the date of hire and is subject to change.
We do not discriminate on the basis of race, color, religion, sex, sexual orientation, gender identity or expression, national origin, age, disability, veteran status, marital status, or based on an individual’s status in any group or class protected by applicable federal, state, and local law. We invite applications from minorities, women, the disabled, protected veterans, and all other qualified applicants.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Marea Therapeutics?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Treatments for Cardiometabolic Diseases
Upgrade to Pro to access all 5 linked drug products and competitive data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo